Sierra Oncology, Inc.
SRRADelisted Jul 1, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001290149
Sierra Oncology, Inc. was delisted on Jul 1, 2022; its insiders filed their last Form 4 on Jul 1, 2022; 109 institutions reported holding it in 13F filings for Q2 2022, worth $1.23B in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Sierra Oncology, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 37 | 46 | +9 |
| Shares | 10.6M | 12.3M | +1.65M (+15.5%) |
| Value | $233.1M | $267.1M | +$34.1M (+14.6%) |
New holders (13)
Institutions that held Sierra Oncology, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 607,600 | $13.2M | 0.98% |
| Paradigm Biocapital Advisors LP | 474,945 | $10.3M | 2.95% |
| Polar Asset Management Partners Inc. | 85,900 | $1.87M | 0.02% |
| Acuta Capital Partners, LLC | 68,500 | $1.49M | 0.63% |
| 683 Capital Management, LLC | 17,856 | $388.0K | 0.02% |
| Crescent Grove Advisors, LLC | 17,786 | $387.0K | 0.04% |
| Gyon Technologies Capital Management, LP | 9,631 | $209.0K | 0.04% |
| Citigroup Inc | 7,344 | $160.0K | 0.00% |
| Acadian Asset Management LLC | 3,668 | $79.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,305 | $28.0K | 0.00% |
| Elmwood Wealth Management, Inc. | 1,140 | $25.0K | 0.01% |
| Bank of America Corp | 616 | $13.0K | 0.00% |
| Rise Advisors, LLC | 250 | $5.43K | 0.01% |
Sold out (4)
Institutions that held Sierra Oncology, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 98,131 | $2.15M |
| Jackson Square Capital, LLC | 9,152 | $201.0K |
| O'Shaughnessy Asset Management, LLC | 41 | $1.00K |
| Brewin Dolphin Ltd | 24 | $526 |